Article
Do the Heterozygous Carriers of a CYP24A1 Mutation Display a Different Biochemical Phenotype Than Wild Types?
The Journal of clinical endocrinology and metabolism - 8 Mar 2021
Brancatella Alessandro, Cappellani Daniele, Kaufmann Martin, Borsari Simona, Piaggi Paolo, Baldinotti Fulvia, Caligo Maria Adelaide, Jones Glenville, Marcocci Claudio, Cetani Filomena
Abstract excerpt
CONTEXT: Human cytochrome P450 24 subfamily A member 1 (CYP24A1) loss-of-function mutations result in impaired activity of the 24-hydroxylase involved in vitamin D catabolism, thus inducing a vitamin D-dependent hypercalcemia. Homozygotes often present an overt clinical phenotype named idiopathic infantile hypercalcemia (IIH), whereas it is debated whether heterozygotes display an abnormal phenotype. OBJECTIVE:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
